Products
Product Name | CAS No. | Specification | Application | Registration |
Idarubicin Hydrochloride (Idarubicin HCl) | 57852-57-0 | 98+% | Topoisomerase inhibitor | Antibiotics inhibitor | Autophagy activator | |
Lamivudine (3TC) | 134678-17-4 | 98+% | ||
Fluocinolone Acetonide | 67-73-2 | 98+% | ||
Exenatide Acetate | 914454-01-6 | 98%Min. HPLC | ||
Fidaxomicin (Lipiarmycin) | 873857-62-6 | 98+% | ||
L-Biopterin (6-Biopterin) | 22150-76-1 | 98+% | ||
Gemcitabine Base (LY 188011) | 95058-81-4 | 98+% | DNA/RNA Synthesis inhibitor | Autophagy activator | Nucleoside Analog/Antimetabolite chemical | Apoptosis related activator | |
Leuprolide Acetate (Leuprorelin Acetate) | 74381-53-6 | 98+% | ||
Bumetanide | 28395-03-1 | 98+% | ||
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate (T9) | 134790-39-9 | 98+% | ||
tert-Butyl [(1S,2R)-1-benzyl-2-hydroxy-3-(isobutylamino)propyl]carbamate | 160232-08-6 | 98+% | ||
Sapropterin Dihydrochloride | 69056-38-8 | 98+% | Cardiovascular Disease | |
Sulfobutyl Ether-β-Cyclodextrin Sodium salt (SBE-β-CD) | 182410-00-0 | 98+% | Hydrotropic Agents inhibitor | Anti-infection chemical | |
Nintedanib (BIBF 1120) | 656247-17-5 | 98+% | VEGFR inhibitor | FGFR inhibitor| PDGFR inhibitor | Src inhibitor | |
Cidofovir Anhydrous | 113852-37-2 | 98+% |